ALLISON BLACKSHER: Open Payments
NPI 1679072169 · SAINT JAMES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 25 payments from 9 companies in 2025. Trend: 2023 $867 · 2024 $684 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $136 |
| ABBVIE INC. | 4 | $91 |
| Exact Sciences Corporation | 2 | $33 |
| Novo Nordisk Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Viatris Specialty LLC | 1 | $15 |
Products named: OTEZLA, VRAYLAR, UBRELVY, REPATHA, Wegovy, CAPLYTA, The Cologuard Plus Collection Kit, Auvelity.
Industry payments across MO — which companies pay providers there.
